Mendelspod
Subscribe
Sign in
Home
Theral's Picks
Archive
About
Page not found
New
Top
Discussion
Synthetic Biology in 2024 with John Cumbers
Listen now | Our annual review of the synthetic biology industry: John Cumbers is back on the show to preview the annual SynBioBeta, the leading global…
Mar 26
•
Theral Timpson
25:14
6
Share this post
Synthetic Biology in 2024 with John Cumbers
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom
Most of the news coming from Illumina has had to do with their leadership in the sequencing instrument space. What is lesser known is that they offer an…
Mar 21
•
Theral Timpson
30:51
15
Share this post
Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo
Today, we feature a new DNA synthesis company out of Sweden that is making a name with long, single-stranded DNA at scale. How long? Over 10,000 bases…
Mar 19
•
Theral Timpson
25:59
16
Share this post
The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy
The rise of RNA therapeutics and cell therapies promises to take us where we’ve never been in medicine. The growing understanding of RNA, mRNA, and…
Mar 12
•
Theral Timpson
22:24
16
Share this post
Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
February 2024
Precision Medicine for Dogs: Christina Lopes, OneHealth
Chapters: 0:00 Number one unmet medical need for dogs 6:25 Using “extra label” for cross species 12:57 Ideal for understanding human cancers 21:25…
Feb 22
•
Theral Timpson
36:05
39
Share this post
Precision Medicine for Dogs: Christina Lopes, OneHealth
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
There’s a new genome editing company that everyone is talking about this year. Tome Biosciences came out of stealth in December, claiming the ability to…
Feb 15
•
Theral Timpson
40:29
38
Share this post
Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Christian Henry of PacBio on Long Reads at Scale, Next Moves
0:00 Long reads at scale has made what difference? 6:15 The long or short of it: How does one decide? 12:31 Long reads in the clinic 20:37 Apton tech to…
Feb 13
•
Theral Timpson
49:15
39
Share this post
Christian Henry of PacBio on Long Reads at Scale, Next Moves
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing
Why aren’t more folks receiving genetic testing? In a study published in JAMA last year, Stanford cancer researcher Alison Kurian found a surprising gap…
Feb 6
•
Theral Timpson
40:22
9
Share this post
Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
January 2024
Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox
Batten disease is a group of neurodegenerative lysosomal storage disorders that result from pathogenic variants in one of 13 CLN genes. Collectively…
Jan 30
•
Theral Timpson
37:30
7
Share this post
Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF
After ten years, the human brain mapping project has achieved some major milestones, says Tom Nowakowski, a researcher at UCSF, on today’s program. He…
Jan 23
•
Theral Timpson
36:23
9
Share this post
What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post
Karen Tumulty, a political writer for the Washington Post, was diagnosed with multiple myeloma. She was told she had five years to live. Then she went…
Jan 16
•
Theral Timpson
23:48
80
Share this post
Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics
Fun fact: we are composed of 90% bacterial cells and 10% human cells. Surely, the company that begins to turn that knowledge into health products will…
Jan 9
•
Theral Timpson
28:59
69
Share this post
Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics
www.mendelspod.com
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts